Value Proposition of Personalized Medicine
Video Categories: ValueJohn Hennessy discusses the benefits of the “personalized medicine toolkit” to help make better decisions
Related Videos

Pathways to a Cancer Stem Cell
Dr Wainberg expands upon what makes these types of cells unique.
Ibrutinib and ABT199 for CLL
Jennifer R. Brown, MD, PhD, at Dana-Farber Cancer Institute in Boston, discusses what she believes are the most important items coming out of ASH for CLL this year. She mentions excellent study results being presented about the drugs ibrutinib and ABT199.